Stem(STEM) - 2025 Q3 - Earnings Call Presentation
2025-10-29 21:00
October 29, 2025 Third Quarter 2025 Financial Results Cautionary Statement Regarding Forward-Looking Statements This presentation, as well as other statements we make, contains "forward-looking statements" within the meaning of the federal securities laws, which include any statements that are not historical facts. Such statements often contain words such as "expect," "may," "can," "believe," "predict," "plan," "potential," "projected," "projections," "forecast," "estimate," "intend," "anticipate," "ambitio ...
Verra Mobility(VRRM) - 2025 Q3 - Earnings Call Presentation
2025-10-29 21:00
Financial Performance - Total revenue reached $262 million, a 16% year-over-year increase[6] - Adjusted EBITDA was $113 million, reflecting an 8% year-over-year growth[6] - Adjusted EPS increased to $037, a 16% year-over-year growth[6] - Free Cash Flow stood at $49 million, with a 43% Free Cash Flow conversion of Adjusted EBITDA[6] Segment Highlights - Government Solutions service revenue grew by 19% year-over-year, driven by red-light camera installations and 11% growth outside of New York City[9] - Commercial Services revenue increased by 7% year-over-year due to increased travel volume, product adoption, and tolling activity[9] - Parking Solutions SaaS and Services revenue grew by 3% year-over-year, driven by increased professional services and SaaS recurring revenue[9] Strategic Initiatives and Outlook - The Board of Directors authorized a $150 million increase to the existing stock repurchase program[9] - The company is increasing its 2025 revenue guidance, driven by the New York City expansion[9] - The New York City Department of Transportation red-light camera expansion program includes a change order authorizing the installation of up to 250 additional red-light cameras in 2025[9] - The company anticipates a total contract value of $963 million over the next 5 years from the New York City contract[45]
Pitney Bowes(PBI) - 2025 Q3 - Earnings Call Presentation
2025-10-29 21:00
Pitney Bowes Third Quarter Earnings October 29, 2025 Forward-Looking Statements and Financial Presentation This document contains "forward-looking statements" about the Company's expected or potential future business and financial performance, including, but not limited to, statements about future revenue and profitability, earnings guidance, future events or conditions, capital allocation strategy, expected cost savings and efficiency improvements, and strategic initiatives and priorities. Forward-looking ...
Morningstar(MORN) - 2025 Q3 - Earnings Call Presentation
2025-10-29 21:00
Q3 2025 Financial Performance - Revenue increased to $617.4 million, representing an 8.4% reported increase and a 9.0% organic increase[13] - Adjusted Operating Income increased to $150.6 million, compared to $130.3 million in Q3 24[13] - Free Cash Flow increased to $160.1 million, a 2.8% increase from $155.8 million in Q3 24[13] - The Adjusted Operating Margin was 24.4%[102] Segment Performance - Morningstar Direct Platform revenue reached $211.1 million, with a 6.3% reported increase and a 6.2% organic increase; Adjusted Operating Income was $93.7 million[49] - PitchBook revenue reached $169.0 million, with a 7.9% reported increase and a 7.7% organic increase; Adjusted Operating Income was $52.9 million[58] - Morningstar Credit revenue reached $91.1 million, with a 28.5% reported increase and a 27.0% organic increase; Adjusted Operating Income was $28.1 million[67] - Morningstar Wealth revenue reached $62.1 million, with a 0.5% reported increase and a 9.8% organic increase; Adjusted Operating Income was $3.1 million[81] - Morningstar Retirement revenue reached $34.2 million, with a 7.5% reported and organic increase; Adjusted Operating Income was $16.9 million[93] Cash Flow and Capital Allocation - Operating Cash Flow was $195.7 million[26] - Capital Allocation included $170.1 million in share repurchases, $35.6 million in capital expenditures, and $19.2 million in dividends paid[27]
Teladoc(TDOC) - 2025 Q3 - Earnings Call Presentation
2025-10-29 21:00
Financial Performance - Q3 2025 - Revenue for 3Q-25 was $626 million, a decrease of 2% year-over-year[4] - Net loss per share for 3Q-25 was $(0.28)[4] - Adjusted EBITDA for 3Q-25 was $69.9 million, a decrease of 16% year-over-year[4] Financial Outlook - FY25 - The company projects FY-25 revenue to be in the range of $2,510 million to $2,539 million[5] - The company projects FY-25 net loss per share to be in the range of $(1.25) to $(1.10)[5] - The company projects FY-25 Adjusted EBITDA to be in the range of $270 million to $287 million[5] Financial Outlook - Q4 2025 - The company projects 4Q-25 revenue to be in the range of $622 million to $652 million[5] - The company projects 4Q-25 net loss per share to be in the range of $(0.25) to $(0.10)[5] - The company projects 4Q-25 Adjusted EBITDA to be in the range of $73 million to $90 million[5] Balance Sheet and Cash Flow - Cash and cash equivalents as of September 30, 2025, were $726 million[36] - Convertible senior notes as of September 30, 2025, were $994 million[36] - Operating cash flow for 3Q-25 was $99 million[36] - Free cash flow for 3Q-25 was $68 million[36]
Rogers (ROG) - 2025 Q3 - Earnings Call Presentation
2025-10-29 21:00
Q3 2025 Financial Performance - Net sales reached $216 million, an increase from $202.8 million in Q2 2025 [13] - Adjusted EBITDA increased to $37.2 million, compared to $23.9 million in Q2 2025 [13] - Adjusted EBITDA margin improved significantly to 17.2%, up from 11.8% in the previous quarter [6, 13] - Adjusted earnings per diluted share rose to $0.90, a substantial increase from $0.34 in Q2 2025 [13] Sales by End Market (Q3 2025) - Industrial sector accounted for 28% of sales, showing growth in all regions [12] - Aerospace & Defense (A&D) contributed 16% of sales, driven by North American commercial aerospace demand [12] - E-mobility represented 14% of sales, remaining consistent with the previous quarter [12] - Portable electronics accounted for 9% of sales, experiencing double-digit growth due to normal seasonality [12] Q4 2025 Guidance - The company projects net sales between $190 million and $205 million [23] - Gross margin is expected to be in the range of 30% to 32% [23] - Adjusted earnings per diluted share are forecasted to be between $0.40 and $0.80 [23]
Carlisle(CSL) - 2025 Q3 - Earnings Call Presentation
2025-10-29 21:00
Third Quarter 2025 Earnings Call October 29, 2025 Forward Looking Statements & Non-GAAP Financial Measures This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements generally use words such as "expect," "foresee," "anticipate," "believe," "project," "should," "estimate," "will," "plans," "intends," "forecast," and similar expressions, and reflect our expectations concerning the future. Such statements are made ...
Bio-Rad(BIO) - 2025 Q3 - Earnings Call Presentation
2025-10-29 21:00
Financial Performance - Q3 2025 - Bio-Rad's Q3 2025 GAAP revenue was $653 million, with a gross margin of 52.6% and an operating margin of 10.0%[6] - The company's Q3 2025 GAAP net cash from operations was $121 million[6] - Bio-Rad's Q3 2025 non-GAAP revenue was also $653 million, with a gross margin of 53.5% and an operating margin of 11.8%[7] - The company's Q3 2025 non-GAAP free cash flow was $89 million[7] Segment and Geographic Revenue Mix - Q3 2025 - Clinical Diagnostics accounted for 60% of the company's revenue, while Life Science accounted for 40%[10] - Americas contributed 47% of the company's revenue, EMEA 34%, and APAC 19%[10] - Life Science Group revenue was $262 million[12, 13] - Clinical Diagnostics Group revenue was $391 million[14] Balance Sheet Highlights - September 30, 2025 - The company's cash and short-term investments totaled $1.419 billion[15] - Long-term debt stood at $1.201 billion[15] - Investment in Sartorius AG was $4.643 billion[15] Full-Year 2025 Outlook - The company maintains its full-year 2025 outlook for currency neutral revenue growth of 0.0% to +1.0%[16] - The company anticipates free cash flow between $310 million and $330 million[16]
Emergent BioSolutions(EBS) - 2025 Q3 - Earnings Call Presentation
2025-10-29 21:00
2025 Third Quarter Financial Results Our Mission: Protect and Save Lives October 29, 2025 1 Safe Harbor Statement/Trademarks This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. All statements, other than statements of historical fact, including statements regarding the future performance of the Company or any of our businesses, our business strategy, future operations, future financial position, future revenues and ear ...
MercadoLibre(MELI) - 2025 Q3 - Earnings Call Presentation
2025-10-29 21:00
INVESTOR PRESENTATION Q3'25 Results October 29, 2025 DISCLAIMERS MercadoLibre, Inc. I 2 IR CONTENT Third Quarter 2025 This presentation may contain forward-looking statements including, but not limited to, statements regarding MercadoLibre, Inc.'s expectations, objectives and progress against strategic priorities; initiatives and strategies related to our products and services; our inability to successfully deliver new products and services; business and market outlook, opportunities, strategies and trends; ...